Edward Harhaj, Ph.D., has been appointed an associate professor of oncology in the Viral Oncology Program. Ed is a basic scientist who is a recognized leader in the area of HTLV-1 research and NF-κB biology. He joins us from the University of Miami School of Medicine and Sylvester Comprehensive Cancer Center where he conducted seminal work in the area of inflammation and viral interference with innate immune responses.
Ed earned his doctoral degree in Molecular Biology and Immunology from Penn State University College of Medicine. During his doctoral studies, he became interested in HTLV-1 and the mechanisms used by the HTLV-1 Tax protein to promote cellular transformation. He remained at Penn State University, Hershey, as an Instructor and then Assistant Professor. While there, he identified key positive and negative regulatory steps in the processing of the precursor p100 molecule into p52 NF-κB. Following his position at Penn, Ed joined the faculty of the University of Miami and focused on the molecular mechanisms by which HTLV-1 activates NF-κB. HTLV-1 is a retrovirus that is linked to two human diseases: a neuroinflammatory disorder termed HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis that is clinically similar to multiple sclerosis and an aggressive T cell leukemia known as adult T cell leukemia/lymphoma (ATLL).
Ivana Gojo, M.D., has been appointed as an associate professor of oncology in the Hematologic Malignancies and Bone Marrow Transplantation Program. In her new position, she will co-direct the leukemia drug development program with Dr. Judy Karp.
Ivana is nationally recognized as a clinical researcher in leukemia and well-known in the Baltimore-Washington region as a clinician and clinical investigator.
Ivana comes to the Kimmel Cancer Center from the University of Maryland Greenebaum Cancer Center where she completed her subspecialty fellowship training in Hematology-Oncology under the mentorship of Drs. Robert Fenton and Judy Karp. After completing her fellowship she was appointed a faculty member at the University of Maryland where she developed a number of leukemia protocols.
She received her medical degree from the University of Zagreb, the leading medical school in Croatia and one of the top medical schools in Southeast Europe. She completed her residency in Internal Medicine at Lennox Hill Hospital in New York City.